Feb 13 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2019 Dec 31, 2018 Dec 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 580 mln 292 mln 310 mln
(+98.2 pct) (+15.3 pct) (-46.6 pct)
Operating 117 mln loss 786 mln loss 290 mln
Recurring 109 mln loss 796 mln loss 310 mln
Net
Net 133 mln loss 748 mln loss 240 mln
EPS 5.07 yen loss 28.51 yen loss 9.13 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T